The rise of spit kits is leaving consumers with lots of data and few answers. Genetic counselors could help people understand these results, but there aren’t enough of them to go around.
Vegans popular on social media often get bullied when they fall short of their fans’ diet demands.
Villages, and sometimes whole regions of the Congo, are misplaced—but the ministry of health and a team of cartographers are racing to get better data.
Everyone is having fewer babies in the U.S.—except women in their 40s.
The stakes are higher now that the virus has reached a city of 1.2 million people.
Research on inmates is logistically difficult and ethically fraught.
A new study links lower socioeconomic status to detrimental brain changes.
What extreme athletes can—and can’t—tell us about human endurance
The DRC's top virologist says the response has been quick, but it started late because of delays in reporting suspected cases.
The highly respected Tim Ziemer left the National Security Council earlier this week. Here’s who will be taking over his duties.
Are electronic medical records and demanding regulations contributing to a historic doctor shortage?
The drug can be extra dangerous when your detective work involves sniffing.
A new study finds police killings exact a toll greater than accidental gun deaths.
Bariatric surgery works, but hundreds of thousands of eligible patients can’t get it.
… and could help explain why humans have so many sleep disruptions later in life.
Often laced into popular illicit drugs, synthetic opioids are killing more people than heroin or OxyContin.
A superlative evaluation of physical health becomes a failed test of character.
The threat of a flu pandemic clouds even his legendary optimism, so he's launching an initiative to prevent one.
The burger, shake, and fries—“enduring icons of American cuisine”— are used to symbolize abundance, accessibility, and dominance while ignoring the dark side of those values.
There’s only one individual-market carrier in Charlottesville, Virginia, and its premiums are too high for many residents to afford.
The company is offering free kits to researchers studying populations in Africa, Asia, and elsewhere—but the ethics are tricky.